ES2123996T3 - Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen. - Google Patents

Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2123996T3
ES2123996T3 ES95923666T ES95923666T ES2123996T3 ES 2123996 T3 ES2123996 T3 ES 2123996T3 ES 95923666 T ES95923666 T ES 95923666T ES 95923666 T ES95923666 T ES 95923666T ES 2123996 T3 ES2123996 T3 ES 2123996T3
Authority
ES
Spain
Prior art keywords
cancer
analogs
etertaxol
antineoplasic
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95923666T
Other languages
English (en)
Inventor
Robert C Kelly
Ilse Gebhard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2123996T3 publication Critical patent/ES2123996T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

ESTA INVENCION PROPORCIONA ANALOGOS DE 7-ETER-TAXOL DE FORMULA (I). LAS COMPOSICIONES DE FORMULA (I) SON UTILES PARA EL TRATAMIENTO DE LOS MISMOS CANCERES PARA LOS QUE SE HA DEMOSTRADO QUE EL TAXOL ES ACTIVO, INCLUYENDO CANCER DE OVARIOS HUMANOS, CANCER DE MAMA, Y MELANOMA MALIGNO ASI COMO CANCER DE PULMON, CANCER GASTRICO, CANCER DE COLON, CANCER DE CABEZA Y CUELLO, Y LEUCEMIA.
ES95923666T 1994-06-28 1995-06-07 Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2123996T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26817994A 1994-06-28 1994-06-28

Publications (1)

Publication Number Publication Date
ES2123996T3 true ES2123996T3 (es) 1999-01-16

Family

ID=23021820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95923666T Expired - Lifetime ES2123996T3 (es) 1994-06-28 1995-06-07 Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.

Country Status (12)

Country Link
EP (1) EP0767786B1 (es)
JP (1) JPH10502077A (es)
CN (1) CN1151740A (es)
AT (1) ATE171170T1 (es)
AU (1) AU2814595A (es)
CA (1) CA2191224A1 (es)
DE (1) DE69504843T2 (es)
DK (1) DK0767786T3 (es)
ES (1) ES2123996T3 (es)
MX (1) MX9700026A (es)
NZ (1) NZ288802A (es)
WO (1) WO1996000724A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US6040466A (en) * 1996-03-25 2000-03-21 Rhone Poulenc Rorer Sa Taxoids, their preparation and pharmaceutical compositions containing them
US6232477B1 (en) 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
US6593482B2 (en) * 1993-02-01 2003-07-15 Aventis Pharma S.A. Methods for preparing new taxoids and pharmaceutical compositions containing them
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
DE19605024A1 (de) * 1996-01-31 1997-08-07 Schering Ag Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
WO1997042948A1 (en) * 1996-05-16 1997-11-20 Bristol-Myers Squibb Company 7-o-methoxymethyl paclitaxel
US5977386A (en) * 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
CZ2003837A3 (cs) 2000-09-22 2004-12-15 Bristol-Myers Squibb Company Způsob pro snížení toxicity při kombinovaných chemoterapiích
TW200300416A (en) * 2001-11-27 2003-06-01 Bristol Myers Squibb Co Method of synthesizing a paclitaxel derivative
KR101444693B1 (ko) * 2011-06-06 2014-09-26 아버 테라퓨틱스 엘엘씨 암 화학요법제의 산에 불안정한 친유성 전구약물
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
CN104086514A (zh) * 2014-06-19 2014-10-08 上海应用技术学院 紫杉醇衍生物及其制备方法
CN107021943B (zh) * 2016-02-02 2020-12-29 中国科学院上海药物研究所 一类7-epi-巴卡亭III衍生物，及其制备方法和用途
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
IL127598A (en) * 1994-01-28 2003-04-10 Upjohn Co Process for preparing isotaxol analogs

Also Published As

Publication number Publication date
CA2191224A1 (en) 1996-01-11
EP0767786A1 (en) 1997-04-16
DE69504843T2 (de) 1999-02-11
MX9700026A (es) 1997-04-30
NZ288802A (en) 1998-05-27
EP0767786B1 (en) 1998-09-16
WO1996000724A1 (en) 1996-01-11
CN1151740A (zh) 1997-06-11
DE69504843D1 (de) 1998-10-22
JPH10502077A (ja) 1998-02-24
DK0767786T3 (da) 1999-06-14
AU2814595A (en) 1996-01-25
ATE171170T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
ES2123996T3 (es) Analogos de 7-etertaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
MX9307777A (es) 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES2181766T3 (es) Analogos de delda 12,13-isotaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2151277T3 (es) Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
PA8503301A1 (es) Compuestos para el tratamiento de la isquemia
AR028948A1 (es) Compuestos novedosos
AR018705A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos.
PA8583201A1 (es) Nuevos compuestos de pirazol como inhibidores del factor de crecimiento transformante (tgf)
SV1999000141A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb
PA8583401A1 (es) Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf)
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
AR023363A1 (es) Compuestos derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina, composicion y uso de los mismos
PA8468401A1 (es) Compuestos para el tratamiento de la isquemia
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
AR018201A1 (es) Compuesto de mesilato de n-(3-etinilfenil)-6,7-bis-(2-metoxietoxi)-4-quinazolinamina, composiciones que los contienen y su uso de dichos compuestos para la preparacion de medicamentos.
MXPA04002042A (es) Compuestos de bencimidazol sustituidos y su uso para el tratamiento del cancer.
AR034059A1 (es) Producto que comprende mikanolido, dihidromikanolido o analogos de los mismos en combinacion con otro agente anticanceroso para uso terapeutico en el tratamiento del cancer
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR022740A1 (es) Analogos opticamente puros de la camptotecina, composiciones farmaceuticas que los contienen y uso de los mismos como agentes antitumorales
MXPA03007317A (es) Derivados de biotina y sus conjugados con agentes quelantes.
DE60111614D1 (de) Taxan-derivate für die behandlung von krebs
ECSP056180A (es) Alquil-estra-1,3,5(10)-trienos 8beta-vinil-11beta-(omega-sustituidos)
ES2101620B1 (es) Nuevo compuesto derivado del cromeno.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 767786

Country of ref document: ES